EQT AB (publ) (EQTS.XC)
| Previous close | 308.10 |
| Open | 308.80 |
| Bid | 304.50 x N/A |
| Ask | 312.90 x N/A |
| Day's range | 308.10 - 308.10 |
| 52-week range | 207.60 - 352.50 |
| Volume | |
| Avg. volume | 107 |
| Market cap | 370.342B |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | 233.41 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.60 (1.17%) |
| Ex-dividend date | 29 Nov 2024 |
| 1y target est | N/A |
- PR Newswire
EQT to sell majority stake in real estate platform idealista in EUR 2.9 billion transaction
EQT is pleased to share that the EQT IX fund ("EQT") has sold its majority stake in idealista (the "Company"). The transaction values idealista, which is the leading real estate platform in Spain, Italy, and Portugal, at EUR 2.9 billion. Cinven has signed an agreement to acquire a 70% stake in the Company. EQT originally acquired idealista in 2020 in a deal that valued the firm at EUR 1.3 billion and will retain an 18 percent share in the Company following the transaction.
- PR Newswire
EQT to acquire Constellation Cold Logistics, the third largest cold storage owner-operator in Europe
EQT is pleased to announce that the EQT Infrastructure VI fund ("EQT") has agreed to acquire Constellation Cold Logistics ("Constellation" or the "Company") from Arcus Infrastructure Partners. Financial details are not disclosed.
- PR Newswire
EQT to acquire majority position to support the growth of CluePoints, a leading provider of AI-powered software solutions used for data interrogation and analytics in clinical trials
EQT is pleased to announce that the EQT Healthcare Growth Strategy and the EQT Growth Fund have agreed to acquire a majority stake in CluePoints (the "Company"), with meaningful reinvestment from the management team and existing shareholders Summit Partners and Clinimetrics SA, which was also a co-founder of the Company.
